Skip to main content
University of Oxford Saïd Business School 25

Top menu

  • Oxford Answers

Main navigation

Main menu
  • Research
    Research
    • Research overview
      Research overview
      • Research seminars
      • Research strategy
    • Research areas
      Research areas
      • Accounting
      • Finance
      • Health Care
      • Impact
      • Innovation
      • International Business
      • Management Science
      • Marketing
      • Major Programme Management
      • Organisation Studies
      • Professional Service Firms
      • Strategy
      • Technology and Operations Management
    • Centres and initiatives
      Centres and initiatives
      • Creative Destruction Lab Oxford
      • Entrepreneurship Centre
      • Oxford Future of Finance and Technology Initiative
      • Oxford Future of Marketing Initiative
      • Oxford Future of Real Estate Initiative
      • Oxford Initiative on AI×SDGs
      • Oxford Initiative on Rethinking Performance
      • Oxford University Centre for Business Taxation
      • Oxford University Centre for Corporate Reputation
      • Private Equity Institute
      • Responsible Business
      • Skoll Centre for Social Entrepreneurship
    • Networks
      Networks
      • CABDyN
      • Oxford Institute of Retail Management
  • Oxford experience
    Oxford experience
    • Coming to Oxford
      Coming to Oxford
      • College experience
      • Living costs
      • Partners and families
      • Visas
    • Scholarships and funding
    • Life at Oxford
      Life at Oxford
      • Learning at Oxford
      • Exploring Oxford
      • Activities, clubs and groups
      • Oxford Union
    • Blogs
    • Career development
      Career development
      • Your career journey
      • Our expertise
    • Life after Oxford
      Life after Oxford
      • Alumni
      • Elumni
  • Events
    Events
    • Events listing
    • Past events
    • Future of Business
    • Oxford Smart Space
  • About us
    About us
    • The School
      The School
      • Our history
      • Our community
      • Diversity and inclusion
      • Climate emergency
      • Rankings, achievements and accreditation
      • School Board and Global Leadership Council
      • Global Leadership Centre
      • Covid-19 information
    • Support us
      Support us
      • Fundraising priorities
      • Donate online
      • How to give
      • Corporate partnerships
      • Community giving
      • Impact and recognition
    • Our people
      Our people
      • Faculty
      • Associate Fellows
      • Academic visitors
      • Recruit our graduates
      • Work for us
    • News
      News
      • Media coverage
      • Media relations contacts
    • Venue hire
      Venue hire
      • Park End Street
      • Egrove Park
      • B&B accommodation at Egrove Park
      • Our services
  • Programmes
    Programmes
    • MBAs
      MBAs
      • MBA
      • 1+1 MBA
      • Executive MBA
    • Degrees
      Degrees
      • BA Economics and Management
      • DPhil Finance
      • DPhil Management
      • MSc Financial Economics
      • MSc Global Healthcare Leadership
      • MSc Law and Finance
      • MSc Major Programme Management
    • Executive Diplomas
      Executive Diplomas
      • Artificial Intelligence for Business
      • Financial Strategy
      • Global Business
      • Organisational Leadership
      • Strategy and Innovation
    • Executive Education
      Executive Education
      • On-campus open programmes
      • Online programmes
      • ​Custom programmes
    • Programme finder
  1. Home
  2. News
  3. Harnessing the power of mentors can transform a startup
  1. Home
  2. News
  3. Harnessing the power of mentors can transform a startup
Shirodaria

Harnessing the power of mentors can transform a startup

Thu, 18th June 2020

Published


Related news

  • Programme

The CEO of a MedTech spin-out from Oxford University described how mentoring helped his team commercialise a new way of diagnosing heart disease.

Founded by four Oxford cardiologists, Caristo Diagnostics has developed a new test that analyses routine heart scans for signs of inflammation in the coronary arteries, which supply blood to the heart. It’s known that inflammation in the coronary arteries is a key feature in the lead up to heart attacks. 

Cardiovascular disease is the leading cause of deaths globally – costing some $1 trillion a year to manage. In the UK alone, nearly 170,000 people die of heart and circulatory diseases every year – more than the population of Oxford.  

Caristo’s technology uses artificial intelligence to analyse routine CT heart scans for signs of inflammation in the coronary arteries. It acts as an early warning system, allowing clinicians to identify patients at highest risk of having a heart attack, as early as possible. This enables them to implement appropriate risk reduction strategies. 

The software is already being used by a top five pharmaceutical company in clinical trials for a novel heart drug. It is now going through regulatory approvals for launch in both the UK and the US later this year.

Over the last nine months, Caristo has been receiving mentoring support from the Creative Destruction Lab (CDL) at Oxford Saïd. CDL is a seed-stage mentoring programme for science and technology-focused start-ups. 

Over a series of four day-long sessions at Oxford Saïd’s campus, the founders were mentored by a group of experienced entrepreneurs, investors, scientists and business professors. 
 


Related news

  • Programme

Pricing ourselves appropriately also means that we will be able to invest more in R&D. Our future plans include new software tests to predict stroke and diabetes risk.

Caristo’s CEO, Dr Cheerag Shirodaria, is an honorary consultant cardiologist at Oxford University Hospitals NHS Trust and previously Cardiovascular Global Therapeutic Area Head at Covance, one of the world’s largest drug development organisations.

He says that a particular piece of advice helped them change their strategy: 

‘The biggest piece of feedback was that our pricing didn’t reflect the value that we were creating. Our software has the potential to save many patients’ lives and bring huge benefits to healthcare providers and economies.

‘Pricing ourselves appropriately also means that we will be able to invest more in R&D. Our future plans include new software tests to predict stroke and diabetes risk.’

One of the mentors that has supported Caristo throughout the programme is Richard Foster, Emeritus Director, McKinsey & Company and Venture Partner at Lux Capital. He says: 

‘I spent time mentoring Caristo because I felt that Caristo’s technology, 10 years in development, has real potential to provide essential, and currently missing, early warning of possible cardiovascular disease in patients. This can be translated into earlier, less invasive, less costly and more effective treatment, saving lives and money.’

Caristo is one of 10 ventures, out of an initial 27, to graduate from the inaugural cohort of CDL-Oxford, which this year focused on artificial intelligence and machine learning. The ventures ranged from the world's first fully automated drug discovery platform to AI-powered waste recognition software.

The programme has given all the ventures the opportunity to speed up their business development, while getting exposure and financial attention from experienced entrepreneurs who act as mentors. Many of them have since gone on to secure fundraising and initial contracts. 

Professor Thomas Hellmann, Professor of Entrepreneurship and Lead for CDL-Oxford, adds:

‘Our first graduating cohort proves the value of CDL: a community of experienced mentors that supports ambitious entrepreneurs. Over nine months, it has enabled 27 science-based AI start-ups to find their footing and direction. With the help of our diverse community of mentors, they have identified their initial customers, clarified their value proposition, and generated real momentum towards building significant commercial and social value.’

The full list of CDL-Oxford graduates can be found here.

From September 2020, CDL-Oxford will be expanding its programme with a new health stream, designed to facilitate the commercialisation of scientific advances in medicine and life sciences. Applications for Health Stream are now open.
 

Footer menu

  • Contact us
  • Find us
  • Press
  • Jobs
  • Website policies
  • Alumni
  • Donate
  • Covid-19

Follow us

  • Twitter
  • LinkedIn
  • YouTube
  • Facebook
  • Instagram
  • WeChat
  • Blogs
  • Advance HE Opens in new tab
  • EFMD Equis accreditations Opens in new tab
  • Global Network for Advanced Management Opens in new tab

Website & Privacy Policies © Saïd Business School 2023 All rights reserved

Back to top